HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cardiology
Cohort
Baseline vitamin D levels linked to semaglutide glycemic and weight outcomes in type 2 diabetes
Higher Vitamin D levels help Semaglutide work better for diabetes.
This observational cohort study of 5,384 adults with type 2 diabetes found that higher baseline vitamin D levels were associated with greate…
New data shows higher Vitamin D levels help Semaglutide lower blood sugar and weight more effectively in diabetes patients.
Frontiers
Apr 28, 2026
Diabetes & Endocrinology
Review of miRNA associations with high-risk diabetes profiles in midlife women
MicroRNA markers linked to diabetes and depression risk in midlife women
This observational study review examines microRNA associations with high-risk profiles in women aged 40 to 64 years within the Diabetes Prev…
Specific microRNA markers were found linked to higher odds of a high-risk profile for diabetes and depression in midlife women.
medRxiv
Apr 28, 2026
Diabetes & Endocrinology
RCT
High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
High cholesterol ratio raises heart risk in diabetics
This post hoc analysis of a randomized controlled trial in 5,006 high-risk type 2 diabetes patients with diabetic retinopathy found that a h…
A routine cholesterol test may reveal hidden heart danger in people with diabetes, even when taking cholesterol drugs.
Apr 27, 2026
Diabetes & Endocrinology
Phase III
Semaglutide high dose for weight reduction in people with Type 2 Diabetes
New drug helps obese diabetics lose weight and control sugar
This randomized controlled trial in 512 people with excess weight and Type 2 Diabetes compared high-dose semaglutide to placebo and lower do…
New research shows a specific injection helps people with obesity and diabetes lose weight and control their blood sugar levels better than …
CT.gov
Apr 27, 2026
Nephrology
Meta-analysis
Individual-participant data meta-analysis shows blood-pressure lowering reduces cardiovascular risk in CKD and non-CKD populations
Blood pressure drugs protect kidneys and hearts across all stages
This individual-participant data meta-analysis pooled results from 46 randomised trials involving 285,124 participants to evaluate blood-pre…
Lowering blood pressure protects the heart and kidneys across all stages of kidney disease, but the benefit is weaker in patients who also h…
Apr 27, 2026
Diabetes & Endocrinology
Cohort
Machine learning model improves early detection of occult diabetic kidney disease in hospitalized patients.
New Tool Spots Hidden Kidney Disease in Type 2 Diabetes Earlier
This retrospective multicenter cohort study evaluated a machine learning model using routine clinical and laboratory data to detect occult d…
A new calculator spots hidden kidney damage in type 2 diabetes using routine blood tests, helping doctors act sooner.
Frontiers
Apr 27, 2026
Genetics & Precision Medicine
Cohort
GenMetS polygenic score association with cardiometabolic risk in Asian populations
New Genetic Score Predicts Heart Risk Decades Earlier in Asian Populations
This cohort study of 670,952 individuals investigated the association between the GenMetS polygenic score and cardiometabolic risk across th…
A new genetic score developed in young Asian women accurately predicts heart and diabetes risk from childhood through adulthood, filling a m…
medRxiv
Apr 27, 2026
Diabetes & Endocrinology
Observational study suggests multi-omic scores improve Type 2 Diabetes risk assessment in UK Biobank and MESA cohorts.
Blood Test Could Predict Your Type 2 Diabetes Risk Better Than Genes Alone
This observational research article synthesizes findings from the UK Biobank and Multi-Ethnic Study of Atherosclerosis (MESA) regarding part…
A new blood test that combines genes with proteins and metabolism can more accurately predict type 2 diabetes risk and who may need insulin.
medRxiv
Apr 26, 2026
Diabetes & Endocrinology
Meta-analysis
Meta-analysis suggests Hatha yoga may improve blood pressure and glucose in non-communicable disease patients.
Simple Yoga Moves Could Help Manage Heart Disease Risks
This meta-analysis evaluated Hatha yoga interventions in patients diagnosed with non-communicable diseases including Type 2 Diabetes and hyp…
Adding yoga to your daily routine may lower blood pressure and blood sugar for people with sedentary lifestyles and heart risks.
Frontiers
Apr 25, 2026
Diabetes & Endocrinology
Meta-analysis
Meta-analysis of dapagliflozin for renal outcomes in type 2 diabetes and CKD
SGLT2 inhibitors lower kidney failure risk in type 2 diabetes patients
This systematic review and meta-analysis of 10 studies synthesized evidence on dapagliflozin for renal outcomes in patients with type 2 diab…
A review of ten studies shows these drugs reduce kidney failure risk in people with type 2 diabetes and kidney disease.
Frontiers
Apr 24, 2026
Rheumatology
RCT
Telemedicine applications in general practice show positive clinical outcomes for chronic diseases
New review shows telemedicine works well for chronic illness.
This structured review of 22 studies, primarily RCTs, evaluated telemedicine applications for patients with chronic somatic diseases in gene…
New evidence suggests telemedicine is safe and effective for managing chronic conditions like diabetes and heart disease.
Frontiers
Apr 24, 2026
Diabetes & Endocrinology
Sys. Review
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models.
How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
This narrative review synthesizes evidence from human studies, animal models, and in vitro experiments regarding microgravity and metabolic …
This research shows that the same health problems astronauts face in space are happening to people on Earth who sit too much, and it may lea…
Frontiers
Apr 24, 2026